Breaking News

Oxford BioTherapeutics and Boehringer Ingelheim extend cancer immunology partnership

The two companies have extended their existing collaboration by a further two years, aiming to develop novel cancer immunotherapies

Catalent adds cryogenic capabilities to support gene development

The facility in Shiga will include the storage, kitting, and distribution of advanced therapies at ultra-low temperatures for clinical trials

Scarlet Therapeutics raises seed funding for rare disease treatment therapies

The platform also has the potential to treat other metabolic diseases requiring enzyme replacement therapy, as well as cancer and autoimmune diseases

Living in a material world

Mass consumption's rise has led to waste on a previously unimaginable scale. Kathy Illingworth, Head of Sustainability and Consulting at Ecoveritas...

20% of European biotechs headquartered in Switzerland

Evidence published in the Swiss Biotech Report reveals why Switzerland is now one of the most popular countries for European biotech companies

Arxada issues first sustainability report

The inaugural sustainability report reinforces the company’s commitment to building a sustainable future, highlights progress made to date and esta...

Accelerating drug discovery with market leading cell line generation

In January 2023, integrated drug discovery company Sygnature Discovery announced the acquisition of SB Drug Discovery, a world-leading provider of...

What to consider for successful GMP Annex 1 implementation

In advance of her presentation at Manufacturing Chemist Live, Dr Nicole Hunter (NH), Head of Global Regulatory and Validation Services at Watson-Ma...

Stablepharma publishes peer-reviewed article on world’s first fridge-free Tetanus diphtheria vaccine

Full recovery of vaccine potency, after 7–10 months at 45°C, was shown by complete protection against supra-lethal doses of active toxins

Touchlight creates giant London DNA manufacturing facility

Facility will have capacity that exceeds today’s global plasmid DNA demand and can enable commercialisation of genetic medicines

Network, learn and innovate at the heart of US pharma

Ahead of CPHI North America, Dr Kevin Robinson (KSR) spoke with Sarah Griffin (SG), Brand Manager at Informa, to get her perspectives on what’s new...

Highly potent formulation development in oncology

Formulation development is a dynamic and experimental process. However, certain challenges are presented to CDMOs that add a layer of unnecessary p...

AstraZeneca’s DELIVER Phase III trial reveals heart failure results

Presented at European Society of Cardiology’s Heart Failure 2023 congress, the trials supported the consistent benefits of Farxiga regardless of he...

New-generation silica nanoparticles: the next big thing in siRNA delivery systems for cancer treatment?

In this article, N4 Pharma's Nigel Theobold, CEO, and Dr David Templeton, Technical Director, consider how a novel silica nanoparticle could offer...

AlzeCure Pharma receives patent for anti-Alzheimer's drug

ACD856 and other substances in the NeuroRestore platform stimulate several important signalling systems and signalling molecules in the brain

Investigating DNA repair inhibitors to treat cancer and other inflammatory diseases

Many current chemotherapy drugs work by causing replication-associated DNA damage that kills individual cancer cells. However, as well as destroyin...

Most Popular

  1. Rx-360 publishes audit standards
  2. Arxada issues first sustainability report
  3. Hypromellose is changing the role of capsules
  4. L.B. Bohle presents world novelties at Interpack
  5. How to avoid sticking and picking in the tableting industry

Inspiration and Learning

Find the right diaphragm valve for pharmaceutical applications - DOWNLOAD THE NEW REPORT
Find the right diaphragm valve for pharmaceutical applications - DOWNLOAD THE NEW REPORT
Cleaning validation and verification in a high potent granulation suite
Cleaning validation and verification in a high potent granulation suite
Manufacturing Chemist in conversation with Cytiva
Manufacturing Chemist in conversation with Cytiva
Manufacturing Chemist in conversation with SGS
Manufacturing Chemist in conversation with SGS
Webinar: Is CBD a promising therapy for mental health disorders?
Webinar: Is CBD a promising therapy for mental health disorders?
Manufacturing Chemist in conversation with Curia
Manufacturing Chemist in conversation with Curia
Medicinal Chemistry Sample Tracking and Management - NEW CATALOGUE
Medicinal Chemistry Sample Tracking and Management - NEW CATALOGUE
Applying AI and new digital technology to Compound Management
Applying AI and new digital technology to Compound Management
Artificial intelligence in the pharmaceutical industry
Artificial intelligence in the pharmaceutical industry
Manufacturing Chemist in conversation with Beneo
Manufacturing Chemist in conversation with Beneo

Careers

Reports

Living in a material world
Living in a material world
Accelerating drug discovery with market leading cell line generation
Accelerating drug discovery with market leading cell line generation
Network, learn and innovate at the heart of US pharma
Network, learn and innovate at the heart of US pharma
New-generation silica nanoparticles: the next big thing in siRNA delivery systems for cancer treatment?
New-generation silica nanoparticles: the next big thing in siRNA delivery systems for cancer treatment?
Investigating DNA repair inhibitors to treat cancer and other inflammatory diseases
Investigating DNA repair inhibitors to treat cancer and other inflammatory diseases
Robotic aseptic processing
Robotic aseptic processing
Experience is everything: excipients and their role in enhancing patient-centricity
Experience is everything: excipients and their role in enhancing patient-centricity
Changes ahead as the US FDA proposes longer national drug codes
Changes ahead as the US FDA proposes longer national drug codes
Collaboration is key to advancing cell and gene therapy
Collaboration is key to advancing cell and gene therapy
CDMOs deliver increased performance for pharma clients with agility and innovation
CDMOs deliver increased performance for pharma clients with agility and innovation